Skip to content

Surgery Partners, Inc. SGRY Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin11.8%0.0pp11.8%-0.6pp12.4%+1.2pp11.2%+0.6pp10.5%-0.7pp
Net margin-2.3%+0.1pp-2.4%+2.9pp-5.2%+0.4pp-5.6%+0.5pp-6.1%-0.7pp
EBITDA margin17.1%0.0pp17.1%+0.2pp16.9%+0.8pp16.1%+0.7pp15.4%-0.7pp
Free cash flow margin6.2%+0.3pp5.9%0.0pp5.9%+0.5pp5.4%0.0pp5.5%-1.3pp
Returns
Return on equity-4.4%0.0pp-4.4%+5.0pp-9.5%+0.3pp-9.7%+0.7pp-10.4%-1.5pp
Return on assets-1%0.0pp-1%+1.2pp-2.2%+0.1pp-2.3%+0.3pp-2.6%-0.3pp
Return on invested capital6.1%-0.1pp6.2%-0.4pp6.5%+0.7pp5.9%+0.3pp5.5%-0.4pp
Efficiency
Asset turnover0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio1.9×0.0×1.9×0.0×1.9×0.0×1.9×0.0×1.9×+0.1×
Quick ratio1.7×0.0×1.7×0.0×1.7×-0.1×1.8×0.0×1.7×+0.1×
Cash ratio0.3×-0.1×0.4×0.0×0.3×-0.1×0.4×0.0×0.4×0.0×
Leverage
Debt-to-equity0.0×+0.1×2.8×0.0×2.8×0.0×2.8×+0.2×
Debt-to-assets0.6×0.0×0.6×0.0×0.6×0.0×0.6×0.0×0.6×0.0×
Net debt / EBITDA8.5×0.0×8.5×+0.1×8.4×-0.5×8.9×-0.5×9.4×+0.8×
Per Share
Book value per share$13.15-2.3%$13.47-1.0%$13.60-1.3%$13.77+0.2%$13.75-3.1%
Valuation
Market capitalization$1.54B-22.8%$2B-28.0%$2.77B+2.6%$2.71B-10.7%$3.03B+12.6%
Enterprise value$6.41B-5.9%$6.82B-8.5%$7.45B+1.5%$7.35B-3.8%$7.64B+8.7%
Price / sales0.5×-0.1×0.6×-0.2×0.8×0.0×0.8×-0.1×+0.1×
Price / book0.9×-0.3×1.2×-0.4×1.6×+0.1×1.5×-0.2×1.7×+0.2×
EV / EBITDA11.2×-0.8×12.1×-1.3×13.4×-0.7×14.1×-1.5×15.6×+1.6×
EV / sales1.9×-0.1×2.1×-0.2×2.3×0.0×2.3×-0.1×2.4×+0.2×
Free cash flow yield13.5%+3.7pp9.8%+2.8pp7%+0.5pp6.5%+0.8pp5.7%-2.1pp
Earnings yield-4.9%-1.0pp-3.9%+2.3pp-6.2%+0.5pp-6.7%-0.3pp-6.4%-0.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Surgery Partners, Inc.'s profit margins?
Surgery Partners, Inc. (SGRY) runs a 23.1% gross margin and a 11.8% operating margin, with a -2.3% net margin.
Where do Surgery Partners, Inc.'s ratios come from?
Every ratio is computed from Surgery Partners, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.